Rapport Therapeutics Inc
NASDAQ:RAPP

Watchlist Manager
Rapport Therapeutics Inc Logo
Rapport Therapeutics Inc
NASDAQ:RAPP
Watchlist
Price: 11.73 USD -5.25% Market Closed
Market Cap: 428.1m USD

Intrinsic Value

The intrinsic value of one RAPP stock under the Base Case scenario is hidden USD. Compared to the current market price of 11.73 USD, Rapport Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

RAPP Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Rapport Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

RAPP looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether RAPP usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
Compare RAPP to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RAPP?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Rapport Therapeutics Inc
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Rapport Therapeutics Inc

Balance Sheet Decomposition
Rapport Therapeutics Inc

Current Assets 291m
Other Current Assets 291m
Non-Current Assets 11m
PP&E 11m
Efficiency

Free Cash Flow Analysis
Rapport Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Rapport Therapeutics Inc

Revenue
0 USD
Operating Expenses
-94m USD
Operating Income
-94m USD
Other Expenses
14m USD
Net Income
-80m USD
Fundamental Scores

RAPP Profitability Score
Profitability Due Diligence

Rapport Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Rapport Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

RAPP Solvency Score
Solvency Due Diligence

Rapport Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Rapport Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RAPP Price Targets Summary
Rapport Therapeutics Inc

Wall Street analysts forecast RAPP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RAPP is 35.7 USD with a low forecast of 28.28 USD and a high forecast of 44.1 USD.

Lowest
Price Target
28.28 USD
141% Upside
Average
Price Target
35.7 USD
204% Upside
Highest
Price Target
44.1 USD
276% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Rapport Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RAPP is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RAPP Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RAPP stock?

The intrinsic value of one RAPP stock under the Base Case scenario is hidden USD.

Is RAPP stock undervalued or overvalued?

Compared to the current market price of 11.73 USD, Rapport Therapeutics Inc is hidden .

Back to Top